Compare GSK Consumer with VADILAL INDUSTRIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs VADILAL INDUSTRIES - Comparison Results

GSK CONSUMER     Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER VADILAL INDUSTRIES GSK CONSUMER/
VADILAL INDUSTRIES
 
P/E (TTM) x 39.1 14.1 278.2% View Chart
P/BV x 11.0 2.8 393.6% View Chart
Dividend Yield % 1.0 0.2 631.4%  

Financials

 GSK CONSUMER   VADILAL INDUSTRIES
EQUITY SHARE DATA
    GSK CONSUMER
Mar-19
VADILAL INDUSTRIES
Mar-19
GSK CONSUMER/
VADILAL INDUSTRIES
5-Yr Chart
Click to enlarge
High Rs7,819950 823.1%   
Low Rs5,832400 1,457.9%   
Sales per share (Unadj.) Rs1,136.9787.7 144.3%  
Earnings per share (Unadj.) Rs233.746.3 504.3%  
Cash flow per share (Unadj.) Rs248.169.8 355.4%  
Dividends per share (Unadj.) Rs105.001.25 8,400.0%  
Dividend yield (eoy) %1.50.2 830.7%  
Book value per share (Unadj.) Rs973.5288.0 338.0%  
Shares outstanding (eoy) m42.067.20 584.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.00.9 700.5%   
Avg P/E ratio x29.214.6 200.5%  
P/CF ratio (eoy) x27.59.7 284.6%  
Price / Book Value ratio x7.02.3 299.1%  
Dividend payout %44.92.7 1,665.6%   
Avg Mkt Cap Rs m287,0834,860 5,907.1%   
No. of employees `0003.80.7 532.4%   
Total wages/salary Rs m6,446538 1,199.1%   
Avg. sales/employee Rs Th12,440.27,854.7 158.4%   
Avg. wages/employee Rs Th1,677.0744.6 225.2%   
Avg. net profit/employee Rs Th2,556.7462.0 553.3%   
INCOME DATA
Net Sales Rs m47,8205,671 843.2%  
Other income Rs m4,326108 4,009.3%   
Total revenues Rs m52,1465,779 902.3%   
Gross profit Rs m11,410720 1,583.9%  
Depreciation Rs m606169 358.3%   
Interest Rs m8141 5.5%   
Profit before tax Rs m15,123519 2,916.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,295185 2,862.1%   
Profit after tax Rs m9,828334 2,946.0%  
Gross profit margin %23.912.7 187.8%  
Effective tax rate %35.035.7 98.1%   
Net profit margin %20.65.9 349.4%  
BALANCE SHEET DATA
Current assets Rs m52,6741,807 2,915.3%   
Current liabilities Rs m18,1401,794 1,011.4%   
Net working cap to sales %72.20.2 31,026.6%  
Current ratio x2.91.0 288.3%  
Inventory Days Days3682 43.5%  
Debtors Days Days2920 147.4%  
Net fixed assets Rs m4,7982,805 171.0%   
Share capital Rs m42172 585.0%   
"Free" reserves Rs m40,5272,002 2,024.6%   
Net worth Rs m40,9472,074 1,974.7%   
Long term debt Rs m0580 0.0%   
Total assets Rs m60,6814,761 1,274.6%  
Interest coverage x1,939.84.7 41,397.6%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.81.2 66.2%   
Return on assets %16.210.0 162.7%  
Return on equity %24.016.1 149.2%  
Return on capital %37.024.8 148.7%  
Exports to sales %012.6 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA717 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,171717 442.5%   
Fx outflow Rs m1,770106 1,669.5%   
Net fx Rs m1,401611 229.4%   
CASH FLOW
From Operations Rs m6,711460 1,459.2%  
From Investments Rs m-3,351-328 1,020.9%  
From Financial Activity Rs m-3,768-96 3,933.2%  
Net Cashflow Rs m-40836 -1,135.9%  

Share Holding

Indian Promoters % 0.0 65.0 -  
Foreign collaborators % 72.5 0.2 48,333.3%  
Indian inst/Mut Fund % 0.8 0.2 381.0%  
FIIs % 12.0 0.0 120,000.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 34.6 42.8%  
Shareholders   26,457 11,093 238.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   AVANTI FEEDS  ITC  JUBILANT FOODWORKS  GOODRICKE  KAVERI SEED  

Compare GSK CONSUMER With:   TIGER BRANDS (S. Africa)  COCA COLA (US)  NESTLE (Switz.)  AVI LTD. (S. Africa)  



Today's Market

SGX Nifty Up 18 Points, IPO Flurry in December, Lakshmi Vilas Bank Fiasco, and Top Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed volatile trading activity on Friday and ended marginally lower, ahead of Q2 GDP data.

Related Views on News

GSK CONSUMER Announces Quarterly Results (3QFY20); Net Profit Up 25.1% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (2QFY20); Net Profit Up 25.3% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.3% YoY). Sales on the other hand came in at Rs 13 bn (up 5.7% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

VADILAL INDUSTRIES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 16, 2019 | Updated on Sep 16, 2019

Here's an analysis of the annual report of VADILAL INDUSTRIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of VADILAL INDUSTRIES. Also includes updates on the valuation of VADILAL INDUSTRIES.

VADILAL INDUSTRIES Announces Quarterly Results (1QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, VADILAL INDUSTRIES has posted a net profit of Rs 377 m (up 16.5% YoY). Sales on the other hand came in at Rs 3 bn (up 12.7% YoY). Read on for a complete analysis of VADILAL INDUSTRIES's quarterly results.

GSK CONSUMER Announces Quarterly Results (1QFY20); Net Profit Up 23.8% (Quarterly Result Update)

Aug 5, 2019 | Updated on Aug 5, 2019

For the quarter ended June 2019, GSK CONSUMER has posted a net profit of Rs 2 bn (up 23.8% YoY). Sales on the other hand came in at Rs 12 bn (up 7.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks(Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits(Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You(Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Is this Sector the Best Contrarian Bet Right Now?(Profit Hunter)

Nov 23, 2020

The risk reward ratio in this beaten down sector may have finally turned for the better.

The Price of Dying, the Cost of Living(The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Apr 15, 2020 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER 5-YR ANALYSIS

COMPARE GSK CONSUMER WITH

MARKET STATS